C
Cytecare Hospitals
A Cancer Treatment Hospital
About Cytecare Hospitals
Cytecare Hospitals, established in November 2016 in Bangalore, India, is a specialized institution dedicated to cancer care. The hospital was founded by a team of entrepreneurs and clinicians, including Suresh Ramu and Dr. Ferzaan Engineer, who serve as co-founders. Suresh Ramu, with a background as a healthcare entrepreneur and former co-founder of a clinical trials company, brings extensive experience in the healthcare sector to his role as CEO. Dr. Ferzaan Engineer has a long-standing career in clinical research and pharmaceutical services, having co-founded and led companies in that space. Their combined expertise in healthcare management and clinical research underpins the hospital's patient-centric and research-oriented approach to oncology.
The institution operates as a 150-bed organ-specific cancer hospital, focusing exclusively on oncology. This specialization allows for a concentrated approach to cancer treatment, from diagnostics to therapy and palliative care. Cytecare's business model is centered on providing comprehensive cancer care services directly to patients. Revenue is generated through the provision of these medical services, which include advanced diagnostics, surgical oncology, radiation oncology, medical oncology, and integrative therapies. The hospital serves cancer patients from India and internationally, positioning itself as a destination for advanced cancer treatment.
Cytecare distinguishes itself through its multidisciplinary Tumour Board approach, where experts from various specialties collaborate to create personalized treatment plans for each patient. This method ensures that patients receive a holistic and well-rounded treatment strategy. The hospital is equipped with advanced medical technology, such as the Elekta Versa HD for radiation therapy, which enables precise targeting of tumors while minimizing damage to surrounding healthy tissue. The facility also emphasizes a research-driven ethos, aiming to integrate clinical research with patient care to improve outcomes.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2025 | $0 | — | Omega Hospitals | ↗ |
| SERIES A✓Equity / VC | May 2018 | $31M | $124M | Goldman Sachs | — |
Growth signals
Latest recorded traffic for Cytecare Hospitals is 22K monthly website visits, up 131.6% over the last three months. Cytecare Hospitals's team grew 3.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Cytecare Hospitals in the Bengaluru ecosystem
The Cytecare Hospitals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Other known investors1 additional known investor
Omega Hospitals
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cytecare Hospitals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cytecare Hospitals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









